Skip to main content

Schneid Yair's Form 4/A amendment

Amended

Galera Therapeutics, Inc. (GRTX) · filed May 1, 2024

Accession no.
0001213900-24-038573
Filed
May 1, 2024, 5:02 PM ET
Trade date
Apr 17, 2014-Apr 19, 2024
Filing delay
3,667 days
Rule 10b5-1 plan
Not checked
Original filed
Feb 26, 2024

This filing lists 21 non-derivative transactions. Open-market purchases total $590.4K. It was filed 3,667 days after the trade.

This amendment replaces 0001213900-24-016923 (filed Feb 26, 2024).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schneid YairCIK 000200823310% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 17, 2014Common StockPPurchaseAcquired+318,150$0.19+$60,448.58,361,353Direct
Apr 17, 2024Common StockPPurchaseAcquired+100,000$0.191+$19,1008,461,353Direct
Apr 17, 2024Common StockPPurchaseAcquired+68,424$0.196+$13,411.18,529,777Direct
Apr 17, 2024Common StockPPurchaseAcquired+241,028$0.20+$48,205.68,770,805Direct
Apr 17, 2024Common StockPPurchaseAcquired+56,900$0.21+$11,9498,827,705Direct
Apr 17, 2024Common StockPPurchaseAcquired+50,000$0.212+$10,6008,877,705Direct
Apr 17, 2024Common StockPPurchaseAcquired+50,000$0.214+$10,7008,927,705Direct
Apr 17, 2024Common StockPPurchaseAcquired+243,100$0.22+$53,4829,170,805Direct
Apr 17, 2024Common StockPPurchaseAcquired+551,217$0.23+$126,779.919,722,022Direct
Apr 17, 2024Common StockPPurchaseAcquired+453,988$0.24+$108,957.1210,176,010Direct
Apr 18, 2024Common StockPPurchaseAcquired+17,211$0.185+$3,184.0410,193,221Direct
Apr 18, 2024Common StockPPurchaseAcquired+100,000$0.1893+$18,93010,293,221Direct
Apr 18, 2024Common StockPPurchaseAcquired+100,000$0.197+$19,70010,393,221Direct
Apr 18, 2024Common StockPPurchaseAcquired+247,600$0.198+$49,024.810,640,821Direct
Apr 18, 2024Common StockPPurchaseAcquired+4,245$0.1998+$848.1510,645,066Direct
Apr 18, 2024Common StockPPurchaseAcquired+4,342$0.1999+$867.9710,649,408Direct
Apr 18, 2024Common StockPPurchaseAcquired+74,202$0.20+$14,840.410,723,610Direct
Apr 19, 2024Common StockPPurchaseAcquired+100$0.1855+$18.5510,723,710Direct
Apr 19, 2024Common StockPPurchaseAcquired+314$0.1874+$58.8410,724,024Direct
Apr 19, 2024Common StockPPurchaseAcquired+215$0.1875+$40.3110,724,239Direct
Apr 19, 2024Common StockPPurchaseAcquired+99,371$0.194+$19,277.9710,823,610Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.